GlassScriptPhysician profile
Omar M Cheema
NPI 1255358743
$11,756.03
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $872 · 2020: $92.54 · 2021: $1,133 · 2022: $910 · 2023: $5,211 · 2024: $3,538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,398 · Food and Beverage: $3,262 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,398.14 |
| Food and Beverage | $3,262.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $4,926.79 | 2023-2024 | Ruby Coil, Indigo System |
| Pfizer INC. | $2,208.38 | 2019-2024 | |
| Abbott Laboratories | $1,123.02 | 2019-2023 | 2nd Gen Centrimag Primary Console |
| Abiomed | $662.00 | 2020-2024 | Impella |
| Medtronic Vascular, INC. | $532.82 | 2019 | |
| Novartis Pharmaceuticals Corporation | $437.54 | 2021-2024 | |
| Boston Scientific Corporation | $375.39 | 2019-2024 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $288.49 | 2023-2024 | Camzyos |
| Medtronic, INC. | $265.48 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $196.42 | 2022-2024 | |
| Cvrx, INC. | $148.50 | 2024 | Barostim Neo System |
| Actelion Pharmaceuticals US, INC. | $103.29 | 2024 | Opsumit, Uptravi |
| Amgen INC. | $81.21 | 2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.59 | 2023-2024 | Lifevest |
| Heartflow, INC. | $56.84 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $46.99 | 2023 | Xarelto |
| Kestra Medical Technology Services, INC. | $39.19 | 2023 | Assure Wcd |
| Philips North America LLC | $33.35 | 2023 | |
| Novo Nordisk INC | $31.31 | 2023 | Ozempic |
| Lexicon Pharmaceuticals, INC. | $26.27 | 2024 | |
| Livanova USA, INC. | $20.23 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.70 | 2023 | Jardiance |
| Terumo Medical Corporation | $19.47 | 2023 | Tr Band, Angio-Seal |
| Inari Medical, INC. | $19.18 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cook Medical LLC | $16.58 | 2023 | Cook Celect |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Cheema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.